THE ROLE OF EGFR AND FOXG1 IN DIFFUSE MIDLINE GLIOMA RESPONSE TO MITOCHONDRIAL-TARGETING DRUGS

$589,680FY2021Defense Health AgencyDOD

Regents Of The University Of Michigan

Investigators